For the first time, the Centre has urged the governor to use his special powers in Scheduled Areas to cancel bauxite mining leases given in Andhra Pradesh's Vishakhapatnam district. Linking the issue of bauxite mining to the growing Maoist violence on the Andhra-Odisha border, the Centre has asked Andhra Pradesh governor ESL Narsimhan to use special powers, bestowed to governors in Scheduled Areas under the Constitution, to cancel the leases. The Centre...

Alarmed by its proactive role, the three ‘pillars’ of our democracy set out to weaken the fourth estate Fundamentalisms do not necessarily announce their arrival by banging a hammer on our heads. Freedoms are often lost in little steps. The process creeps in quietly but insidiously. The path is often complex and defies a simple narrative. But here’s a straightforward fact: a concerted attempt is being made to censor, control...

The Union government has decided to intensify its operations against the CPI (Maoist) by launching the third and fourth phase of its multi-winged, coordinated stratagem to squeeze the expanse of what the Naxalites now refer to as the ‘ring of fire' (part of the red corridor). However, several ministries are not extending any cooperation. Union Minister for Rural Development Jairam Ramesh raised the issue in his letter to Prime Minister Manmohan...

-PTI President Pratibha Patil today announced she will forego the accommodation allotted to her for use after retirement following reports that the land for the house was given in violation of rules. “Considering the fact that the issue has got linked with the issue of war widows’ accommodation… the President has chosen to forego the aforesaid allotment of accommodation proposed to be made to her as her post-retirement home in Pune,” Rashtrapati...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...